- SEK1.82bn
- SEK1.72bn
- SEK569.95m
- 79
- 25
- 37
- 41
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 18.96 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | -6.91% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.6 | ||
| Price to Tang. Book | 9.29 | ||
| Price to Free Cashflow | 30.98 | ||
| Price to Sales | 3.18 | ||
| EV to EBITDA | 17.55 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 8.15% | ||
| Return on Equity | 8.74% | ||
| Operating Margin | 12.36% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | 142.63 | 187.09 | 246.35 | 294.89 | 569.95 | 606.5 | 679.5 | 29.47% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -75.93 | +228.69 | +45.7 | -2.73 | +130.61 | -20.86 | +30.93 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Stille AB is a Sweden-based company engaged in the development, manufacture, and marketing of technical medical equipment. The product portfolio is divided into two business lines. The Surgery business area develops, produces and markets handcrafted, forged surgical instruments for all fields of open surgery, with an emphasis on cardiovascular surgery, and reconstructive and aesthetic plastic surgery. Its products include scissors, forceps, artery forceps, needle holders and clamps, among others. The Patient Positioning area develops and manufactures two main groups of procedure-specific specialized tables for cardiovascular surgery and gynecology, urology and urodynamic examinations. As of December 31, 2011, the Company had two wholly owned subsidiaries, Stille Surgical Inc. and Stille Incentive AB. As of December 30, 2011, the it's largest shareholder was Linc Invest AB (39.81%). On September 2, 2013, the Company sold its business unit, Sonesta, to ADDvise Lab Solutions publ AB.
Directors
- Goran Brorsson CHM (65)
- Hanna Ernestam Wilkman PRE
- Pontus Luning OTH (50)
- Ralph Tamm OTH (45)
- Tomas Anderzon DRC
- Bengt Julander DRC (68)
- Sirpa Makipaa DRC (56)
- Stefan Tell DRC (47)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- September 12th, 1984
- Public Since
- August 29th, 1997
- No. of Shareholders
- 2,452
- No. of Employees
- 142
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
OMX Nordic Exchange Stockholm- Shares in Issue
- 8,985,447
- Address
- Ekbacken 11, TORSHAELLA, 644 30
- Web
- https://www.stille.se/
- Phone
- +46 858858000
- Auditors
- Radek KB
Upcoming Events for STIL
Q2 2025 Stille AB Earnings Release
Q3 2025 Stille AB Earnings Release
Similar to STIL
Acarix AB
OMX Nordic Exchange Stockholm
AddLife AB
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
Arcoma AB
OMX Nordic Exchange Stockholm
FAQ
What is the Stille AB share price?
As of Today at 23:27 UTC, shares in Stille AB are trading at SEK202.00. This share price information is delayed by 15 minutes.
How has the Stille AB share price performed this year?
Shares in Stille AB last closed at SEK202.00 and the price had moved by +5.21% over the past 365 days. In terms of relative price strength the Stille AB share price has outperformed the FTSE Global All Cap Index by +2.57% over the past year.
What are the analyst and broker recommendations for Stille AB?
The overall consensus recommendation for Stille AB is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Stille AB dividend yield?
Stille AB does not currently pay a dividend.
Does Stille AB pay a dividend?
Stille AB does not currently pay a dividend.
When does Stille AB next pay dividends?
Stille AB does not currently pay a dividend.
How do I buy Stille AB shares?
To buy shares in Stille AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Stille AB?
As of the previous close price of SEK202.00, shares in Stille AB had a market capitalisation of SEK1.82bn.
Where are Stille AB shares listed?
Here are the trading details for Stille AB:
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: STIL
What kind of share is Stille AB?
Based on an overall assessment of its quality, value and momentum Stille AB is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Stille AB share price forecast for 2025?
The analyst consensus target price for shares in Stille AB is SEK272.00. That is 34.65% above the last closing price of SEK202.00.
Analysts covering Stille AB currently have a consensus Earnings Per Share (EPS) forecast of SEK9.70 for the next financial year.
Find out moreWhat is the trend in the Stille AB share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Stille AB. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -6.6%.
As of the last closing price of SEK202.00, shares in Stille AB were trading -8.44% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Stille AB PE Ratio?
The Stille AB PE ratio based on its reported earnings over the past 12 months is 18.96. The shares last closed at SEK202.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Stille AB?
Stille AB's management team is headed by:
- Goran Brorsson - CHM
- Hanna Ernestam Wilkman - PRE
- Pontus Luning - OTH
- Ralph Tamm - OTH
- Tomas Anderzon - DRC
- Bengt Julander - DRC
- Sirpa Makipaa - DRC
- Stefan Tell - DRC